Form 4: Opus Genetics SVP of Finance, Amy Zaremba Rabourn, Reports Stock Disposal
SEC Form 4 Filing
Amy Zaremba Rabourn, SVP of Finance at Opus Genetics, reported disposing of 8,190 shares of common stock on February 4, 2025, at a price of $1.14 per share.
Summary
- On February 6, 2025, Amy Zaremba Rabourn, SVP of Finance at Opus Genetics, filed a Form 4 with the SEC.
- The report details a transaction on February 4, 2025, where Ms. Rabourn disposed of 8,190 shares of Opus Genetics common stock.
- The shares were disposed of at a price of $1.14 per share.
- Following the transaction, Ms. Rabourn beneficially owns 74,468 shares of Opus Genetics common stock directly.
- Ms. Rabourn has also granted Sharon Goldbach power of attorney to handle SEC filings on her behalf.
Sentiment
Score: 5
Explanation: The document is a routine SEC filing reporting a stock disposal. It doesn't inherently convey positive or negative sentiment.
Industry Context
Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.
Stakeholder Impact
- The stock disposal by a company insider may be of interest to shareholders.
Key Dates
| Date | Description |
|---|---|
| 02/04/2025 | Date of stock disposal transaction. |
| 02/06/2025 | Date of Power of Attorney execution. |
| 02/06/2025 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.